Association of the Serum Glucose Level with Fetal-Maternal Complications of Gestational Diabetes with Insulin Therapy

Gestational diabetes mellitus (GDM) is one of the important problems in pregnant women. This study conducted to determine association the level of serum glucose with fetal-maternal complications of gestational diabetes with insulin therapy. This study has been conducted as an Existing Data Study, so medical records of all pregnant women with GDM that have been treated with insulin during 2 years of study has been selected using census. The information was obtained using, medical records data. Mean level of serum glucose before and after treatment in different times according to correct level of serum glucose did not show statistical significant (P>0.05). Apgar score, time of stay in NICU, weight at the birth, base on correct level of serum glucose did not show statistical significant (P>0.05). Gestational age at the delivery, stay in hospital, diagnosis and fetal-maternal complications between two groups did not show statistical significant (P>0.05). It seems we can with screening and diagnostic GDM with suitable control of level of serum glucose and insulin therapy reduce incidence of fetal-maternal complications.